


| Key | % Net Assets | 
|---|---|
| 2.8% | |
| 1.9% | |
| 1.9% | |
| 1.8% | |
| 91.6% | 
| Name | % Net Assets | 
|---|---|
| BP | 2.8% | 
| Vodafone | 1.9% | 
| GlaxoSmithKline | 1.9% | 
| HSBC | 1.8% | 
| Royal Dutch Shell | 1.1% | 
| RBS | 1.1% | 
| AstraZeneca | 0.9% | 
| Barclays | 0.8% | 
| HBOS | 0.8% | 
| Lloyds TSB | 0.6% | 
No asset data available.
| Date | 20-May-2024 | 
|---|---|
| Bid | 11.57p | 
| Offer | 12.14p | 
| Currency | GBP | 
| Change | 0.005p | 
| % | -0.04% | 
| YTD change | 11.86p | 
| YTD % | n/a | 
| Fund Inception | 26/01/1993 | 
|---|---|
| Fund Manager | Chris Childs | 
| TER | 1.74 (30-Apr-2011) | 
| Minimum Investment | |
|---|---|
| Initial | £2500 | 
| Additional | £500 | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | 5.00% | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.01 | 
| Sharpe ratio | -0.10 | 
You are here: research